Seeking Alpha

GXDX
Genoptix, Inc.

5/27/2012, 4:31 PM ET
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
GXDX Market Currents more »
  • January 24, 2011 Novartis (NVS) pays $470M to buy Genoptix (GXDX). The $25/share deal is a 27% premium to Genoptix's closing price on Friday, and will allow Novartis to speed development of companion diagnostics. GXDX +25.6% to $24.82. NVS +0.3%.
    Comment!
GXDX in Focus more »
GXDX Press Releases and Filings more »
Currently, there are no press releases or filings on GXDX.
GXDX Cramer more »
Currently, there are no Cramer articles on GXDX.
GXDX Instablog posts more »
  • KELYB, PPWE, GXDX, EVCA, EXXI - Stock Market Update From DrStockPick.com!
    Sun, Feb 13, 2011 • HotDrStockNews • Comment!
  • Can the Biotech Run Continue?
    Fri, Jan 14, 2011 • Philip Davis • Comment!
  • Magic Formula Investing Weekly Roundup 11/14/2010
    Sun, Nov 14, 2010 • MagicDiligence • Comment!
  • Cancer Catalyst Calendar Updated => Rx Investors.com
    Tue, Nov 9, 2010 • Justin M. Hall • Comment!
  • RXI's NEW Cancer Catalyst Calendar ==> Rx Investors.com
    Sun, Oct 17, 2010 • Justin M. Hall • Comment!
Write a post on GXDX
GXDX StockTalks
GXDX vs. ETF Alternatives
Company Description
Currently, there's no company description for GXDX.